Literature DB >> 12956619

Use of inhaler devices in pediatric asthma.

Fernando Maria De Benedictis1, David Selvaggio.   

Abstract

Inhalation is the preferred route for asthma therapy, since it offers a rapid onset of drug action, requires smaller doses, and reduces systemic effects compared with other routes of administration. Unfortunately, inhalation devices are frequently used in an empirical manner rather than on evidence-based awareness.A wide variety of nebulizers are available. Conventional jet nebulizers are highly inefficient, as much of the aerosol is wasted during exhalation. However, incorporating an extra open vent into the system has considerably increased the amount of drug that patients receive. Breath-assisted open vent nebulizers limit the loss of aerosol during exhalation, but are dependent on the patient's inspiratory flow. Ultrasonic nebulizers produce a high mass output and have a short nebulization time, but are inefficient for delivering suspensions or viscous solutions. Adaptive aerosol delivery devices release a precise dose that is tailored to the individual patient's breathing pattern. Nebulizers have several drawbacks, and their use should be limited to patients who cannot correctly manage other devices.Pressurized metered-dose inhalers (pMDI) are practical, cheap and multidose. However, there are several problems with their use. Breath-actuated MDI are easy to use and can be activated by very low flow. However, young children may not be able to use them efficiently. Dry powder inhalers (DPI) are portable and easy to use. They are indicated either for rescue bronchodilator therapy or for regular treatment with inhaled corticosteroids and long-acting bronchodilators. The use of spacers reduces oropharyngeal deposition and improves drug delivery to the lung. Spacers do not require patient coordination, but some general rules must be followed for their optimal use.Thus, the choice of a delivery device mainly depends on the age of the patient, the drug to be administered and the condition to be treated. Proper education is also essential when prescribing an inhalation device.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12956619     DOI: 10.2165/00148581-200305090-00005

Source DB:  PubMed          Journal:  Paediatr Drugs        ISSN: 1174-5878            Impact factor:   3.022


  65 in total

1.  Asthma drug delivery devices for children.

Authors:  C O'Callaghan; P W Barry
Journal:  BMJ       Date:  2000-03-11

2.  Drug delivery from jet nebulisers.

Authors:  M L Everard; A R Clark; A D Milner
Journal:  Arch Dis Child       Date:  1992-05       Impact factor: 3.791

3.  Comparison of the antiasthmatic, oropharyngeal, and systemic glucocorticoid effects of budesonide administered through a pressurized aerosol plus spacer or the Turbuhaler dry powder inhaler.

Authors:  J H Toogood; F A White; J C Baskerville; L J Fraher; B Jennings
Journal:  J Allergy Clin Immunol       Date:  1997-02       Impact factor: 10.793

Review 4.  Antiasthmatic drug delivery in children.

Authors:  Elizabeth Biggart; Andrew Bush
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

5.  Poor inhalation technique, even after inhalation instructions, in children with asthma.

Authors:  A W Kamps; B van Ewijk; R J Roorda; P L Brand
Journal:  Pediatr Pulmonol       Date:  2000-01

6.  The conventional ultrasonic nebulizer proved inefficient in nebulizing a suspension.

Authors:  K Nikander; M Turpeinen; P Wollmer
Journal:  J Aerosol Med       Date:  1999

Review 7.  On the use of dry powder inhalers in situations perceived as constrained.

Authors:  L Borgström
Journal:  J Aerosol Med       Date:  2001

8.  The Sophia Anatomical Infant Nose-Throat (Saint) model: a valuable tool to study aerosol deposition in infants.

Authors:  H M Janssens; J C de Jongste; W J Fokkens; S G Robben; K Wouters; H A Tiddens
Journal:  J Aerosol Med       Date:  2001

9.  Aerosol delivery to wheezy infants: a comparison between a nebulizer and two small volume spacers.

Authors:  J H Wildhaber; S G Devadason; M J Hayden; E Eber; Q A Summers; P N LeSouëf
Journal:  Pediatr Pulmonol       Date:  1997-03

10.  Facemasks versus mouthpieces for aerosol treatment of asthmatic children.

Authors:  D Lowenthal; M Kattan
Journal:  Pediatr Pulmonol       Date:  1992-11
View more
  6 in total

1.  Drug delivery systems in children.

Authors:  Stephen Lowis
Journal:  Paediatr Drugs       Date:  2008       Impact factor: 3.022

Review 2.  A path to successful patient outcomes through aerosol drug delivery to children: a narrative review.

Authors:  Arzu Ari
Journal:  Ann Transl Med       Date:  2021-04

3.  Wheeze in childhood: is the spacer good enough?

Authors:  Veena Rajkumar; Barathi Rajendra; Choon How How; Seng Bin Ang
Journal:  Singapore Med J       Date:  2014-11       Impact factor: 1.858

4.  International consensus on (ICON) pediatric asthma.

Authors:  N G Papadopoulos; H Arakawa; K-H Carlsen; A Custovic; J Gern; R Lemanske; P Le Souef; M Mäkelä; G Roberts; G Wong; H Zar; C A Akdis; L B Bacharier; E Baraldi; H P van Bever; J de Blic; A Boner; W Burks; T B Casale; J A Castro-Rodriguez; Y Z Chen; Y M El-Gamal; M L Everard; T Frischer; M Geller; J Gereda; D Y Goh; T W Guilbert; G Hedlin; P W Heymann; S J Hong; E M Hossny; J L Huang; D J Jackson; J C de Jongste; O Kalayci; N Aït-Khaled; S Kling; P Kuna; S Lau; D K Ledford; S I Lee; A H Liu; R F Lockey; K Lødrup-Carlsen; J Lötvall; A Morikawa; A Nieto; H Paramesh; R Pawankar; P Pohunek; J Pongracic; D Price; C Robertson; N Rosario; L J Rossenwasser; P D Sly; R Stein; S Stick; S Szefler; L M Taussig; E Valovirta; P Vichyanond; D Wallace; E Weinberg; G Wennergren; J Wildhaber; R S Zeiger
Journal:  Allergy       Date:  2012-06-15       Impact factor: 13.146

Review 5.  Mask Use with Spacers/Valved Holding Chambers and Metered Dose Inhalers among Children with Asthma.

Authors:  Anna Volerman; Uma Balachandran; Michelle Siros; Mary Akel; Valerie G Press
Journal:  Ann Am Thorac Soc       Date:  2021-01

6.  Targeting inhaled aerosol delivery to upper airways in children: Insight from computational fluid dynamics (CFD).

Authors:  Prashant Das; Eliram Nof; Israel Amirav; Stavros C Kassinos; Josué Sznitman
Journal:  PLoS One       Date:  2018-11-20       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.